|
|
|
Personal data sheet |
Print preview VALIDITY EXPIRED
Publications |
2015
from data base, 2017. X. 11. |
Huleatt P B, Khoo M L, Chua Y Y, Tan T W, Liew R S, Balogh B, Deme R, Goeloencser F, Magyar K, Sheela D P, Ho H K, Sperlagh B, Matyus P, Chai C L L: Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s disease, JOURNAL OF MEDICINAL CHEMISTRY 58: (3) pp. 1400-1419. type of document: Journal paper/Article number of independent citations: 11 language: English DOI |
2015
from data base, 2017. X. 11. |
Kornélia Tekes, Zita Pöstényi, Erzsébet B Faigl, Kálmán Magyar, András Polyák, György Trencsényi, Lajos Balogh, Huba Kalász: Distribution of N-methyl-14C-labeled selegiline in the rat, JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 111: pp. 147-152. type of document: Journal paper/Article language: English URL |
2015
from data base, 2017. X. 11. |
Kalász H, Doležal R, Tekes K, Magyar K, Csermely T, Hosztafi S: Comparative lipophilicity of morphine derivatives, JPC - JOURNAL OF PLANAR CHROMATOGRAPHY - MODERN TLC 28: (2) pp. 126-132. type of document: Journal paper/Review paper number of independent citations: 1 language: English URL |
2014
from data base, 2017. X. 11. |
Kalasz H, Magyar K, Szoke E, Adeghate E, Adem A, Hasan MY, Nurulain SM, Tekes K: Metabolism of Selegiline [(-)-Deprenyl)], CURRENT MEDICINAL CHEMISTRY 21: (13) pp. 1522-1530. type of document: Journal paper/Article number of independent citations: 4 language: English DOI |
2013
from data base, 2017. X. 11. |
Tábi T, Szöko É, Vécsei L, Magyar K: The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease, EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 9: (5) pp. 629-636. type of document: Journal paper/Review paper number of independent citations: 6 language: English URL |
2011
from data base, 2017. X. 11. |
Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S, Keller E, Horvath MC, Nag S, Hermecz I, Magyar K, Halldin C: Activated MAO-B in the brain of Alzheimer patients, demonstrated by [C-11]-L-deprenyl using whole hemisphere autoradiography, NEUROCHEMISTRY INTERNATIONAL 58: (1) pp. 60-68. type of document: Journal paper/Article number of independent citations: 60 language: English DOI |
2011
from data base, 2017. X. 11. |
Magyar K: The pharmacology of selegiline., INTERNATIONAL REVIEW OF NEUROBIOLOGY 100: pp. 65-84. type of document: Journal paper/Article number of independent citations: 30 language: English DOI |
2010
from data base, 2017. X. 11. |
Magyar K, Szende B, Jenei V, Tábi T, Pálfi M, Szöko É: R-deprenyl: Pharmacological spectrum of its activity, NEUROCHEMICAL RESEARCH 35: (12) pp. 1922-1932. type of document: Journal paper/Article number of independent citations: 14 language: English DOI |
2004
from data base, 2017. X. 11. |
Magyar K, Pálfi M, Tábi T, Kalász H, Szende B, Szökő É: Pharmacological aspects of (-)-deprenyl, CURRENT MEDICINAL CHEMISTRY 11: (15) pp. 2017-2031. type of document: Journal paper/Review paper number of independent citations: 50 language: English DOI |
1972
from data base, 2017. X. 11. |
Knoll J, Magyar K: Some puzzling pharmacological effects of monoamine oxidase inhibitors, ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 5: pp. 393-408. type of document: Journal paper/Article number of independent citations: 917 language: English
|
| Number of independent citations to these publications: | 1093 |
|
|
|
|
|
|
|